Ark Angel Alliance recently reported that the group has now invested more than half a million dollars in Arkansas-affiliated companies since they began investing in 2020.
Ark Angel Alliance brings accredited investors together to evaluate angel investment opportunities. The group’s current portfolio includes five companies, including SFC Fluidics, MAIA Biotechnology, Loloft, and Vascugenix, to name a few. The group evaluates deals from across the nation, but gives preference to Arkansas-affiliated deals. Ark Angel Alliance is open to accredited investors and invites them to participate in evaluating investment opportunities.
Angel groups fill a funding niche between informal investment from family and friends and formal venture capital. The number of angel organizations has more than tripled since 1999, with the Center for Venture Research reporting more than 300,000 active angels across the United States in 2019. Recent estimates from the Center for Venture Research also report that angel groups provided $23.9 billion in start-up financing to nearly 63,730 ventures in 2019.